1887

Journal of General Virology header logo

Volume 90, Issue 3

Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins Free

Abstract

Approximately 15 % of human prion disease is associated with autosomal-dominant pathogenic mutations in the prion protein (PrP) gene. Previous attempts to model these diseases in mice have expressed human PrP mutations in murine PrP, but this may have different structural consequences. Here, we describe transgenic mice expressing human PrP with P102L or E200K mutations and methionine (M) at the polymorphic residue 129. Although no spontaneous disease developed in aged animals, these mice were readily susceptible to prion infection from patients with the homotypic pathogenic mutation. However, while variant Creutzfeldt–Jakob disease (CJD) prions transmitted infection efficiently to both lines of mice, markedly different susceptibilities to classical (sporadic and iatrogenic) CJD prions were observed. Prions from E200K and classical CJD M129 homozygous patients, transmitted disease with equivalent efficiencies and short incubation periods in human PrP 200K, 129M transgenic mice. However, mismatch at residue 129 between inoculum and host dramatically increased the incubation period. In human PrP 102L, 129M transgenic mice, short disease incubation periods were only observed with transmissions of prions from P102L patients, whereas classical CJD prions showed prolonged and variable incubation periods irrespective of the codon 129 genotype. Analysis of disease-related PrP (PrP) showed marked alteration in the PrP glycoform ratio propagated after transmission of classical CJD prions, consistent with the PrP point mutations directly influencing PrP assembly. These data indicate that P102L or E200K mutations of human PrP have differing effects on prion propagation that depend upon prion strain type and can be significantly influenced by mismatch at the polymorphic residue 129.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.007930-0
2009-03-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/3/546.html?itemId=/content/journal/jgv/10.1099/vir.0.007930-0&mimeType=html&fmt=ahah

References

  1. Asante E. A., Linehan J., Desbruslais M., Joiner S., Gowland I., Wood A., Welch J., Hill A. F., Lloyd S. other authors 2002; BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358–6366 [CrossRef]
     [Google Scholar]
  2. Asante E. A., Linehan J., Gowland I., Joiner S., Fox K., Cooper S., Osiguwa O., Gorry M., Welch J. other authors 2006; Dissociation of pathological and molecular phenotype of variant Creutzfeldt–Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A 103:10759–10764 [CrossRef]
     [Google Scholar]
  3. Baker H. E., Poulter M., Crow T. J., Frith C. D., Lofthouse R., Ridley R. M., Collinge J. 1991; Amino acid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 337:1286 (letter
    [Google Scholar]
  4. Barbanti P., Fabbrini G., Salvatore M., Petraroli R., Cardone F., Maras B., Equestre M., Macchi G., Lenzi G. L., Pocchiari M. 1996; Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann–Straussler–Scheinker disease (PrP-P102L mutation). Neurology 47:734–741 [CrossRef]
     [Google Scholar]
  5. Barron R. M., Thomson V., Jamieson E., Melton D. W., Ironside J., Will R., Manson J. C. 2001; Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070–5078 [CrossRef]
     [Google Scholar]
  6. Bessen R. A., Marsh R. F. 1994; Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868
     [Google Scholar]
  7. Bishop M. T., Hart P., Aitchison L., Baybutt H. N., Plinston C., Thomson V., Tuzi N. L., Head M. W., Ironside J. W. other authors 2006; Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398 [CrossRef]
     [Google Scholar]
  8. Brown P., Galvez S., Goldfarb L. G., Nieto A., Cartier L., Gibbs C. J., Jr & Gajdusek D. C. 1992; Familial Creutzfeldt–Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 112:65–67 [CrossRef]
     [Google Scholar]
  9. Brown P., Gibbs C. J. Jr, Rodgers Johnson P., Asher D. M., Sulima M. P., Bacote A., Goldfarb L. G., Gajdusek D. C. 1994; Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513–529 [CrossRef]
     [Google Scholar]
  10. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.-P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. 1992; Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577–582 [CrossRef]
     [Google Scholar]
  11. Butefisch C. M., Gambetti P., Cervenakova L., Park K. Y., Hallett M., Goldfarb L. G. 2000; Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study. Neurology 55:517–522 [CrossRef]
     [Google Scholar]
  12. Chapman J., Brown P., Goldfarb L. G., Arlazoroff A., Gajdusek D. C., Korczyn A. D. 1993; Clinical heterogeneity and unusual presentations of Creutzfeldt–Jakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 56:1109–1112 [CrossRef]
     [Google Scholar]
  13. Chiesa R., Piccardo P., Ghetti B., Harris D. A. 1998; Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339–1351 [CrossRef]
     [Google Scholar]
  14. Collinge J. 1997; Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet 6:1699–1705 [CrossRef]
     [Google Scholar]
  15. Collinge J. 1999; Variant Creutzfeldt–Jakob disease. Lancet 354:317–323 [CrossRef]
     [Google Scholar]
  16. Collinge J. 2001; Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24:519–550 [CrossRef]
     [Google Scholar]
  17. Collinge J. 2005; Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76:906–919 [CrossRef]
     [Google Scholar]
  18. Collinge J., Clarke A. 2007; A general model of prion strains and their pathogenicity. Science 318:930–936 [CrossRef]
     [Google Scholar]
  19. Collinge J., Palmer M. S. 1992 In Prion Diseases of Humans and Animals Edited by Prusiner S. B., Collinge J., Powell J., Anderton B. London: Ellis Horwood;
     [Google Scholar]
  20. Collinge J., Prusiner S. B. 1992; In Prion Diseases of Humans and Animals . , 1st edn. pp 5–12Edited by Prusiner S. B., Collinge J., Powell J., Anderton B. London: Ellis Horwood;
  21. Collinge J., Harding A. E., Owen F., Poulter M., Lofthouse R., Boughey A. M., Shah T., Crow T. J. 1989; Diagnosis of Gerstmann–Straussler syndrome in familial dementia with prion protein gene analysis. Lancet 2:15–17
     [Google Scholar]
  22. Collinge J., Owen F., Poulter M., Leach M., Crow T. J., Rossor M. N., Hardy J., Mullan M. J., Janota I., Lantos P. L. 1990; Prion dementia without characteristic pathology. Lancet 336:7–9 [CrossRef]
     [Google Scholar]
  23. Collinge J., Palmer M. S., Dryden A. J. 1991; Genetic predisposition to iatrogenic Creutzfeldt–Jakob disease. Lancet 337:1441–1442 [CrossRef]
     [Google Scholar]
  24. Collinge J., Brown J., Hardy J., Mullan M., Rossor M. N., Baker H., Crow T. J., Lofthouse R., Poulter M. other authors 1992; Inherited prion disease with 144 base pair gene insertion; 2; Clinical and pathological features. Brain 115:687–710 [CrossRef]
     [Google Scholar]
  25. Collinge J., Palmer M. S., Campbell T. A., Sidle K. C. L., Carroll D., Harding A. E. 1993; Inherited prion disease (PrP lysine 200) in Britain: two case reports. BMJ 306:301–302 [CrossRef]
     [Google Scholar]
  26. Collinge J., Palmer M. S., Sidle K. C. L., Hill A. F., Gowland I., Meads J., Asante E., Bradley R., Doey L. J., Lantos P. L. 1995; Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378:779–783 [CrossRef]
     [Google Scholar]
  27. Collinge J., Beck J., Campbell T., Estibeiro K., Will R. G. 1996a; Prion protein gene analysis in new variant cases of Creutzfeldt–Jakob disease. Lancet 348:56
     [Google Scholar]
  28. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F. 1996b; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690 [CrossRef]
     [Google Scholar]
  29. Colucci M., Moleres F. J., Xie Z. L., Ray-Chaudhury A., Gutti S., Butefisch C. M., Cervenakova L., Wang W., Goldfarb L. G. other authors 2006; Gerstmann–Straussler–Scheinker: a new phenotype with ‘curly’ PrP deposits. J Neuropathol Exp Neurol 65:642–651 [CrossRef]
     [Google Scholar]
  30. Crozet C., Bencsik A., Flamant F., Lezmi S., Samarut J., Baron T. 2001; Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep 2:952–956 [CrossRef]
     [Google Scholar]
  31. Gambetti P., Kong Q., Zou W., Parchi P., Chen S. G. 2003; Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213–239 [CrossRef]
     [Google Scholar]
  32. Goldfarb L. G., Korczyn A. D., Brown P., Chapman J., Gajdusek D. C. 1990; Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt–Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638
     [Google Scholar]
  33. Goldfarb L. G., Brown P., Mitrova E., Cervenakova L., Goldin L., Korczyn A. D., Chapman J., Galvez S., Cartier L. other authors 1991; Creutzfeldt–Jakob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol 7:477–486 [CrossRef]
     [Google Scholar]
  34. Goldfarb L. G., Petersen R. B., Tabaton M., Brown P., LeBlanc A. C., Montagna P., Cortelli P., Julien J., Vital C. other authors 1992; Fatal familial insomnia and familial Creutzfeldt–Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808 [CrossRef]
     [Google Scholar]
  35. Griffith J. S. 1967; Self replication and scrapie. Nature 215:1043–1044 [CrossRef]
     [Google Scholar]
  36. Hainfellner J. A., Brantner-Inthaler S., Cervenáková L., Brown P., Kitamoto T., Tateishi J., Diringer H., Liberski P. P., Regele H. other authors 1995; The original Gerstmann–Straussler–Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5:201–211 [CrossRef]
     [Google Scholar]
  37. Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., DeArmond S. J., Prusiner S. B., Lingappa V. R. 1998; A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827–834 [CrossRef]
     [Google Scholar]
  38. Hill A. F., Collinge J. 2000; In Prions – A Challenge for Science, Medicine and Public Health System in Contributions to Microbiology . , 7th edn. pp 48–57Edited by Rabenau H. F., Cinatl, Doerr. Karger H. W.
  39. Hill A. F., Collinge J. 2003; Subclinical prion infection. Trends Microbiol 11:578–584 [CrossRef]
     [Google Scholar]
  40. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J. 1997; The same prion strain causes vCJD and BSE. Nature 389:448–450 [CrossRef]
     [Google Scholar]
  41. Hill A. F., Joiner S., Wadsworth J. D., Sidle K. C., Bell J. E., Budka H., Ironside J. W., Collinge J. 2003; Molecular classification of sporadic Creutzfeldt–Jakob disease. Brain 126:1333–1346 [CrossRef]
     [Google Scholar]
  42. Hill A. F., Joiner S., Beck J., Campbell T. A., Dickinson A., Poulter M., Wadsworth J. D., Collinge J. 2006; Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685 [CrossRef]
     [Google Scholar]
  43. Hogan B., Beddington R., Costantini F., Lacy E. 1994 Manipulating the Mouse Embryo. A Laboratory Manual, 2nd edn. pp 1–497
     [Google Scholar]
  44. Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. 1989; Linkage of a prion protein missense variant to Gerstmann–Straussler syndrome. Nature 338:342–345 [CrossRef]
     [Google Scholar]
  45. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. 1990; Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590 [CrossRef]
     [Google Scholar]
  46. Hsiao K., Meiner Z., Kahana E., Cass C., Kahana I., Avrahami D., Scarlato G., Abramsky O., Prusiner S. B., Gabizon R. 1991; Mutation of the prion protein in Libyan Jews with Creutzfeldt–Jakob disease. N Engl J Med 324:1091–1097 [CrossRef]
     [Google Scholar]
  47. Hsiao K. K., Groth D., Scott M., Yang S.-L., Serban H., Rapp D., Foster D., Torchia M., DeArmond S. J., Prusiner S. B. 1994; Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A 91:9126–9130 [CrossRef]
     [Google Scholar]
  48. Kascsak R. J., Rubenstein R., Merz P. A., Tonna DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693
     [Google Scholar]
  49. Khalili-Shirazi A., Summers L., Linehan J., Mallinson G., Anstee D., Hawke S., Jackson G. S., Collinge J. 2005; PrP glycoforms are associated in a strain-specific ratio in native PrPSc . J Gen Virol 86:2635–2644 [CrossRef]
     [Google Scholar]
  50. Kovacs G. G., Trabattoni G., Hainfellner J. A., Ironside J. W., Knight R. S., Budka H. 2002; Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582 [CrossRef]
     [Google Scholar]
  51. Kretzschmar H. A., Honold G., Seitelberger F., Feucht M., Wessely P., Mehraein P., Budka H. 1991; Prion protein mutation in family first reported by Gerstmann, Straussler, and Scheinker. Lancet 337:1160 [CrossRef]
     [Google Scholar]
  52. Kretzschmar H. A., Kufer P., Riethmuller G., DeArmond S. J., Prusiner S. B., Schiffer D. 1992; Prion protein mutation at codon 102 in an Italian family with Gerstmann–Straussler–Scheinker syndrome. Neurology 42:809–810 [CrossRef]
     [Google Scholar]
  53. Lee H. S., Brown P., Cervenáková L., Garruto R. M., Alpers M. P., Gajdusek D. C., Goldfarb L. G. 2001; Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 183:192–196 [CrossRef]
     [Google Scholar]
  54. Lysek D. A., Nivon L. G., Wuthrich K. 2004; Amino acid sequence of the Felis catus prion protein. Gene 341:249–253 [CrossRef]
     [Google Scholar]
  55. Majtenyi C., Brown P., Cervenakova L., Goldfarb L. G., Tateishi J. 2000; A three-sister sibship of Gerstmann–Straussler–Scheinker disease with a CJD phenotype. Neurology 54:2133–2137 [CrossRef]
     [Google Scholar]
  56. Mallucci G. R., Campbell T. A., Dickinson A., Beck J., Holt M., Plant G., De Pauw K. W., Hakin R. N., Clarke C. E. other authors 1999; Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 122:1823–1837 [CrossRef]
     [Google Scholar]
  57. Manson J. C., Jamieson E., Baybutt H., Tuzi N. L., Barron R., McConnell I., Somerville R., Ironside J., Will R. other authors 1999; A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18:6855–6864 [CrossRef]
     [Google Scholar]
  58. Mead S. 2006; Prion disease genetics. Eur J Hum Genet 14:273–281 [CrossRef]
     [Google Scholar]
  59. Mead S., Stumpf M. P., Whitfield J., Beck J., Poulter M., Campbell T., Uphill J., Goldstein D., Alpers M. P. other authors 2003; Balancing selection at the prion protein gene consistent with prehistoric kuru-like epidemics. Science 300:640–643 [CrossRef]
     [Google Scholar]
  60. Mead S., Poulter M., Beck J., Webb T., Campbell T., Linehan J., Desbruslais M., Joiner S., Wadsworth J. D. other authors 2006; Inherited prion disease with six octapeptide repeat insertional mutation – molecular analysis of phenotypic heterogeneity. Brain 129:2297–2317 [CrossRef]
     [Google Scholar]
  61. Muramoto T., Tanaka T., Kitamoto N., Sano C., Hayashi Y., Kutomi T., Yutani C., Kitamoto T. 2000; Analyses of Gerstmann–Straussler syndrome with 102Leu219Lys using monoclonal antibodies that specifically detect human prion protein with 219Glu. Neurosci Lett 288:179–182 [CrossRef]
     [Google Scholar]
  62. Nazor K. E., Kuhn F., Seward T., Green M., Zwald D., Purro M., Schmid J., Biffiger K., Power A. M. other authors 2005; Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 24:2472–2480 [CrossRef]
     [Google Scholar]
  63. Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. 1991; Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352:340–342 [CrossRef]
     [Google Scholar]
  64. Parchi P., Chen S. G., Brown P., Zou W., Capellari S., Budka H., Hainfellner J., Reyes P. F., Golden G. T. other authors 1998; Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann–Sträussler–Scheinker disease. Proc Natl Acad Sci U S A 95:8322–8327 [CrossRef]
     [Google Scholar]
  65. Petersen R. B., Parchi P., Richardson S. L., Urig C. B., Gambetti P. 1996; Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271:12661–12668 [CrossRef]
     [Google Scholar]
  66. Piccardo P., Dlouhy S. R., Lievens P. M. J., Young K., Bird T. D., Nochlin D., Dickson D. W., Vinters H. V., Zimmerman T. R. other authors 1998; Phenotypic variability of Gerstmann–Straussler–Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57:979–988 [CrossRef]
     [Google Scholar]
  67. Piccardo P., Manson J. C., King D., Ghetti B., Barron R. M. 2007; Accumulation of prion protein in the brain that is not associated with transmissible disease. Proc Natl Acad Sci U S A 104:4712–4717 [CrossRef]
     [Google Scholar]
  68. Poulter M., Baker H. F., Frith C. D., Leach M., Lofthouse R., Ridley R. M., Shah T., Owen F., Collinge J. other authors 1992; Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 115:675–685 [CrossRef]
     [Google Scholar]
  69. Prusiner S. B. 1982; Research on scrapie. Lancet 2:494–495
     [Google Scholar]
  70. Prusiner S. B. 1998; Prions. Proc Natl Acad Sci U S A 95:13363–13383 [CrossRef]
     [Google Scholar]
  71. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F. E., Prusiner S. B. 1998; Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157–1165 [CrossRef]
     [Google Scholar]
  72. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Wälchli M., Torchia M., Groth D., Carlson G. other authors 1989; Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847–857 [CrossRef]
     [Google Scholar]
  73. Simon E. S., Kahana E., Chapman J., Treves T. A., Gabizon R., Rosenmann H., Zilber N., Korczyn A. D. 2000; Creutzfeldt–Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann Neurol 47:257–260 [CrossRef]
     [Google Scholar]
  74. Tateishi J., Kitamoto T., Hoque M. Z., Furukawa H. 1996; Experimental transmission of Creutzfeldt–Jakob disease and related diseases to rodents. Neurology 46:532–537 [CrossRef]
     [Google Scholar]
  75. Telling G. C., Haga T., Torchia M., Tremblay P., DeArmond S. J., Prusiner S. B. 1996a; Interactions between wild-type and mutant prion proteins modulate neurodegeneration transgenic mice. Genes Dev 10:1736–1750 [CrossRef]
     [Google Scholar]
  76. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B. 1996b; Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082 [CrossRef]
     [Google Scholar]
  77. Tremblay P., Ball H. L., Kaneko K., Groth D., Hegde R. S., Cohen F. E., DeArmond S. J., Prusiner S. B., Safar J. G. 2004; Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 78:2088–2099 [CrossRef]
     [Google Scholar]
  78. Wadsworth J. D., Collinge J. 2007; Update on human prion disease. Biochim Biophys Acta 1772:598–609 [CrossRef]
     [Google Scholar]
  79. Wadsworth J. D., Joiner S., Hill A. F., Campbell T. A., Desbruslais M., Luthert P. J., Collinge J. 2001; Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 358:171–180 [CrossRef]
     [Google Scholar]
  80. Wadsworth J. D., Hill A. F., Beck J., Collinge J. 2003; Molecular and clinical classification of human prion disease. Br Med Bull 66:241–254 [CrossRef]
     [Google Scholar]
  81. Wadsworth J. D., Asante E., Desbruslais M., Linehan J., Joiner S., Gowland I., Welch J., Stone L., Lloyd S. other authors 2004; Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306:1793–1796 [CrossRef]
     [Google Scholar]
  82. Wadsworth J. D., Joiner S., Linehan J., Cooper S., Powell C., Mallinson G., Buckell J., Gowland I., Asante E. other authors 2006; Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 129:1557–1569 [CrossRef]
     [Google Scholar]
  83. Wadsworth J. D., Powell C., Beck J., Joiner S., Linehan J., Brandner S., Mead S., Collinge J. 2008; Molecular diagnosis of human prion disease. Methods Mol Biol 459:197–227
     [Google Scholar]
  84. Webb T. E. F., Poulter M., Beck J., Uphill J., Adamson G., Campbell T., Linehan J., Powell C., Brandner S. other authors 2008; Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 131:2632–2646 [CrossRef]
     [Google Scholar]
  85. Whittington M. A., Sidle K. C. L., Gowland I., Meads J., Hill A. F., Palmer M. S., Jefferys J. G. R., Collinge J. 1995; Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nat Genet 9:197–201 [CrossRef]
     [Google Scholar]
  86. Wildegger G., Liemann S., Glockshuber R. 1999; Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nat Struct Biol 6:550–553 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.007930-0
Loading
Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins
J. Gen. Virol. 90, 546 (2009); https://doi.org/10.1099/vir.0.007930-0
/content/journal/jgv/10.1099/vir.0.007930-0
/content/journal/jgv/10.1099/vir.0.007930-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error